Teva, MRK settle Vytorin/Zetia US patent case: http://www.bloomberg.com/news/2011-07-08/teva-won-t-sell-generic-vytorin-until-2017-settling-merck-patent-lawsuit.html The settlement terms have not been disclosed. Unless MYL prevails against MRK in a separate lawsuit, Vytorin/Zetia will not go generic in the US until 2017.